Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

High brain distribution of a new central nervous system drug candidate despite its P-glycoprotein-mediated efflux at the mouse blood-brain barrier.

Taccola C, Cartot-Cotton S, Valente D, Barneoud P, Aubert C, Boutet V, Gallen F, Lochus M, Nicolic S, Dodacki A, Smirnova M, Cisternino S, Declèves X, Bourasset F.

Eur J Pharm Sci. 2018 May 30;117:68-79. doi: 10.1016/j.ejps.2018.02.005. Epub 2018 Feb 7.

PMID:
29427702
2.

Expression and function of Abcg4 in the mouse blood-brain barrier: role in restricting the brain entry of amyloid-β peptide.

Dodacki A, Wortman M, Saubaméa B, Chasseigneaux S, Nicolic S, Prince N, Lochus M, Raveu AL, Declèves X, Scherrmann JM, Patel SB, Bourasset F.

Sci Rep. 2017 Oct 17;7(1):13393. doi: 10.1038/s41598-017-13750-0.

3.

Blood-brain and retinal barriers show dissimilar ABC transporter impacts and concealed effect of P-glycoprotein on a novel verapamil influx carrier.

Chapy H, Saubaméa B, Tournier N, Bourasset F, Behar-Cohen F, Declèves X, Scherrmann JM, Cisternino S.

Br J Pharmacol. 2016 Feb;173(3):497-510. doi: 10.1111/bph.13376. Epub 2016 Jan 15.

4.

Age-Dependent Regulation of the Blood-Brain Barrier Influx/Efflux Equilibrium of Amyloid-β Peptide in a Mouse Model of Alzheimer's Disease (3xTg-AD).

Do TM, Dodacki A, Alata W, Calon F, Nicolic S, Scherrmann JM, Farinotti R, Bourasset F.

J Alzheimers Dis. 2016;49(2):287-300. doi: 10.3233/JAD-150350.

PMID:
26484906
5.

Altered cerebral vascular volumes and solute transport at the blood-brain barriers of two transgenic mouse models of Alzheimer's disease.

Do TM, Alata W, Dodacki A, Traversy MT, Chacun H, Pradier L, Scherrmann JM, Farinotti R, Calon F, Bourasset F.

Neuropharmacology. 2014 Jun;81:311-7. doi: 10.1016/j.neuropharm.2014.02.010. Epub 2014 Mar 12.

PMID:
24631967
6.

Brain uptake of a fluorescent vector targeting the transferrin receptor: a novel application of in situ brain perfusion.

Alata W, Paris-Robidas S, Emond V, Bourasset F, Calon F.

Mol Pharm. 2014 Jan 6;11(1):243-53. doi: 10.1021/mp400421a. Epub 2013 Nov 22.

PMID:
24215184
7.

Oatp1a4 and an L-thyroxine-sensitive transporter mediate the mouse blood-brain barrier transport of amyloid-β peptide.

Do TM, Bedussi B, Chasseigneaux S, Dodacki A, Yapo C, Chacun H, Scherrmann JM, Farinotti R, Bourasset F.

J Alzheimers Dis. 2013;36(3):555-61. doi: 10.3233/JAD-121891.

PMID:
23635403
8.

New highly sensitive rodent and human tests for soluble amyloid precursor protein alpha quantification: preclinical and clinical applications in Alzheimer's disease.

Rose C, Peoc'h K, Chasseigneaux S, Paquet C, Dumurgier J, Bourasset F, Calon F, Laplanche JL, Hugon J, Allinquant B.

BMC Neurosci. 2012 Jul 23;13:84. doi: 10.1186/1471-2202-13-84.

9.

Formulations based on alpha cyclodextrin and soybean oil: an approach to modulate the oral release of lipophilic drugs.

Hamoudi MC, Bourasset F, Domergue-Dupont V, Gueutin C, Nicolas V, Fattal E, Bochot A.

J Control Release. 2012 Aug 10;161(3):861-7. doi: 10.1016/j.jconrel.2012.05.032. Epub 2012 May 23.

PMID:
22634090
10.

Long-circulating perfluorooctyl bromide nanocapsules for tumor imaging by 19FMRI.

Diou O, Tsapis N, Giraudeau C, Valette J, Gueutin C, Bourasset F, Zanna S, Vauthier C, Fattal E.

Biomaterials. 2012 Aug;33(22):5593-602. doi: 10.1016/j.biomaterials.2012.04.037. Epub 2012 May 9.

PMID:
22575831
11.

The prolongation of the lifespan of rats by repeated oral administration of [60]fullerene.

Baati T, Bourasset F, Gharbi N, Njim L, Abderrabba M, Kerkeni A, Szwarc H, Moussa F.

Biomaterials. 2012 Jun;33(19):4936-46. doi: 10.1016/j.biomaterials.2012.03.036. Epub 2012 Apr 10. Erratum in: Biomaterials. 2012 Sep;33(26):6292-4.

PMID:
22498298
12.

Conformation of surface-decorating dextran chains affects the pharmacokinetics and biodistribution of doxorubicin-loaded nanoparticles.

Alhareth K, Vauthier C, Bourasset F, Gueutin C, Ponchel G, Moussa F.

Eur J Pharm Biopharm. 2012 Jun;81(2):453-7. doi: 10.1016/j.ejpb.2012.03.009. Epub 2012 Mar 21.

PMID:
22465096
13.

ABCG2- and ABCG4-mediated efflux of amyloid-β peptide 1-40 at the mouse blood-brain barrier.

Do TM, Noel-Hudson MS, Ribes S, Besengez C, Smirnova M, Cisternino S, Buyse M, Calon F, Chimini G, Chacun H, Scherrmann JM, Farinotti R, Bourasset F.

J Alzheimers Dis. 2012;30(1):155-66. doi: 10.3233/JAD-2012-112189.

PMID:
22391220
14.

Direct evidence of abca1-mediated efflux of cholesterol at the mouse blood-brain barrier.

Do TM, Ouellet M, Calon F, Chimini G, Chacun H, Farinotti R, Bourasset F.

Mol Cell Biochem. 2011 Nov;357(1-2):397-404. doi: 10.1007/s11010-011-0910-6. Epub 2011 Jun 10.

PMID:
21660464
15.

Reduction of the cerebrovascular volume in a transgenic mouse model of Alzheimer's disease.

Bourasset F, Ouellet M, Tremblay C, Julien C, Do TM, Oddo S, LaFerla F, Calon F.

Neuropharmacology. 2009 Mar;56(4):808-13.

PMID:
19705573
16.

Diffusion of docosahexaenoic and eicosapentaenoic acids through the blood-brain barrier: An in situ cerebral perfusion study.

Ouellet M, Emond V, Chen CT, Julien C, Bourasset F, Oddo S, LaFerla F, Bazinet RP, Calon F.

Neurochem Int. 2009 Dec;55(7):476-82. doi: 10.1016/j.neuint.2009.04.018. Epub 2009 May 13.

PMID:
19442696
17.

Reduced intestinal absorption of dipeptides via PepT1 in mice with diet-induced obesity is associated with leptin receptor down-regulation.

Hindlet P, Bado A, Kamenicky P, Deloménie C, Bourasset F, Nazaret C, Farinotti R, Buyse M.

J Biol Chem. 2009 Mar 13;284(11):6801-8. doi: 10.1074/jbc.M805564200. Epub 2009 Jan 14.

18.

Effect of interleukin-2 pretreatment on paclitaxel absorption and tissue disposition after oral and intravenous administration in mice.

Hosten B, Abbara C, Petit B, Dauvin A, Bourasset F, Farinotti R, Gonin P, Bonhomme-Faivre L.

Drug Metab Dispos. 2008 Aug;36(8):1729-35. doi: 10.1124/dmd.107.019091. Epub 2008 May 28.

PMID:
18508881
19.

In situ mouse carotid perfusion model: glucose and cholesterol transport in the eye and brain.

Cattelotte J, André P, Ouellet M, Bourasset F, Scherrmann JM, Cisternino S.

J Cereb Blood Flow Metab. 2008 Aug;28(8):1449-59. doi: 10.1038/jcbfm.2008.34. Epub 2008 Apr 30.

PMID:
18446168
20.

A functional in vitro model of rat blood-brain barrier for molecular analysis of efflux transporters.

Perrière N, Yousif S, Cazaubon S, Chaverot N, Bourasset F, Cisternino S, Declèves X, Hori S, Terasaki T, Deli M, Scherrmann JM, Temsamani J, Roux F, Couraud PO.

Brain Res. 2007 May 30;1150:1-13. Epub 2007 Mar 12.

PMID:
17434463
21.
22.
23.

Expression, up-regulation, and transport activity of the multidrug-resistance protein Abcg2 at the mouse blood-brain barrier.

Cisternino S, Mercier C, Bourasset F, Roux F, Scherrmann JM.

Cancer Res. 2004 May 1;64(9):3296-301.

24.

Evidence for an active transport of morphine-6-beta-d-glucuronide but not P-glycoprotein-mediated at the blood-brain barrier.

Bourasset F, Cisternino S, Temsamani J, Scherrmann JM.

J Neurochem. 2003 Sep;86(6):1564-7.

25.

Nonlinear accumulation in the brain of the new taxoid TXD258 following saturation of P-glycoprotein at the blood-brain barrier in mice and rats.

Cisternino S, Bourasset F, Archimbaud Y, Sémiond D, Sanderink G, Scherrmann JM.

Br J Pharmacol. 2003 Apr;138(7):1367-75.

26.

Supplemental Content

Loading ...
Support Center